These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 21425619

  • 1. [Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: effects on plasma proteins and coagulation factor VII].
    Stanojković Z, Antić A.
    Vojnosanit Pregl; 2011 Jan; 68(1):51-6. PubMed ID: 21425619
    [Abstract] [Full Text] [Related]

  • 2. [Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates].
    Stanojković Z, Antić A, Stojanović M.
    Vojnosanit Pregl; 2011 Jun; 68(6):489-94. PubMed ID: 21818915
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light].
    Antić A, Stanojković Z, Macukanović-Golubović L, Jelić M.
    Vojnosanit Pregl; 2012 Jan; 69(1):22-6. PubMed ID: 22397292
    [Abstract] [Full Text] [Related]

  • 4. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
    Hornsey VS, Drummond O, Morrison A, McMillan L, MacGregor IR, Prowse CV.
    Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
    [Abstract] [Full Text] [Related]

  • 5. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J, Rock G.
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [Abstract] [Full Text] [Related]

  • 6. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
    Balint B, Jovicic-Gojkov D, Todorovic-Balint M, Subota V, Pavlovic M, Goodrich R.
    Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
    [Abstract] [Full Text] [Related]

  • 7. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ, Ettinger A, Buytaert-Hoefen KA, Hendrix BK, Maldonado-Codina G, Rock G, Giclas PC, Goodrich RP.
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [Abstract] [Full Text] [Related]

  • 8. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD, Saakadze N, Bowen R, Newman JL, Karatela S, Gordy P, Marschner S, Roback J, Hillyer CD.
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [Abstract] [Full Text] [Related]

  • 9. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
    Feys HB, Van Aelst B, Devreese K, Devloo R, Coene J, Vandekerckhove P, Compernolle V.
    Vox Sang; 2014 May; 106(4):307-15. PubMed ID: 24460692
    [Abstract] [Full Text] [Related]

  • 10. Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.
    Ettinger A, Miklauz MM, Hendrix BK, Bihm DJ, Maldonado-Codina G, Goodrich RP.
    Transfus Apher Sci; 2011 Feb; 44(1):25-31. PubMed ID: 21251884
    [Abstract] [Full Text] [Related]

  • 11. The effectiveness of riboflavin photochemical-mediated virus inactivation and changes in protein retention in fresh-frozen plasma treated using a flow-based treatment device.
    Zhu L, Pan J, Wei C, Wang H, Xiang R, Zhang J, Wang D.
    Transfusion; 2015 Jan; 55(1):100-7. PubMed ID: 25070346
    [Abstract] [Full Text] [Related]

  • 12. Towards the understanding of the UV light, riboflavin and additive solution contributions to the in vitro lesions observed in Mirasol®-treated platelets.
    Abonnenc M, Crettaz D, Sonego G, Escolar G, Tissot JD, Prudent M.
    Transfus Clin Biol; 2019 Nov; 26(4):209-216. PubMed ID: 31563447
    [Abstract] [Full Text] [Related]

  • 13. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R.
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
    Keil SD, Ragan I, Yonemura S, Hartson L, Dart NK, Bowen R.
    Vox Sang; 2020 Aug; 115(6):495-501. PubMed ID: 32311760
    [Abstract] [Full Text] [Related]

  • 15. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
    Tormey CA, Santhanakrishnan M, Smith NH, Liu J, Marschner S, Goodrich RP, Hendrickson JE.
    Transfusion; 2016 Apr; 56(4):863-72. PubMed ID: 26643781
    [Abstract] [Full Text] [Related]

  • 16. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
    Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP.
    Transfus Med Rev; 2008 Apr; 22(2):133-53. PubMed ID: 18353253
    [Abstract] [Full Text] [Related]

  • 17. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.
    Bakkour S, Chafets DM, Wen L, van der Meer PF, Mundt JM, Marschner S, Goodrich RP, Busch MP, Lee TH.
    Vox Sang; 2014 Nov; 107(4):351-9. PubMed ID: 24976130
    [Abstract] [Full Text] [Related]

  • 18. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
    Ettinger A, Miklauz MM, Hendrix BK, Bihm DJ, Maldonado-Codina G, Goodrich RP.
    Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.
    Keil SD, Bowen R, Marschner S.
    Transfusion; 2016 Dec; 56(12):2948-2952. PubMed ID: 27805261
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma evaluated with INR-quantification.
    Stanojkovic Z, Balint B, Antic A, Todorovic M, Ostojic G, Pavlovic M.
    Transfus Apher Sci; 2012 Aug; 47(1):33-7. PubMed ID: 22465578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.